BioCentury | May 31, 2010
Company News

CPEX, Arcadia Capital Advisors LLC deal

...it would explore strategic alternatives (see BioCentury, May 17). CPEX Pharmaceuticals Inc. (NASDAQ:CPEX), Exeter, N.H. Arcadia Capital Advisors LLC...
BioCentury | May 17, 2010
Company News

CPEX, Arcadia Capital Advisors LLC deal

...recommended that shareholders reject a $16 per share unsolicited tender offer from private equity firm Arcadia Capital...
...Markets Corp. is advising CPEX (see BioCentury, May 3). CPEX Pharmaceuticals Inc. (NASDAQ:CPEX), Exeter, N.H. Arcadia Capital Advisors LLC...
BioCentury | May 3, 2010
Company News

CPEX, Arcadia Capital Advisors LLC deal

...Markets Corp. is advising CPEX (see BioCentury, Jan. 18). CPEX Pharmaceuticals Inc. (NASDAQ:CPEX), Exeter, N.H. Arcadia Capital Advisors LLC...
BioCentury | Jan 18, 2010
Company News

CPEX deal

...In an SEC filing, private equity firm Arcadia Capital proposed to acquire the 88% of CPEX it...
Items per page:
1 - 4 of 4
BioCentury | May 31, 2010
Company News

CPEX, Arcadia Capital Advisors LLC deal

...it would explore strategic alternatives (see BioCentury, May 17). CPEX Pharmaceuticals Inc. (NASDAQ:CPEX), Exeter, N.H. Arcadia Capital Advisors LLC...
BioCentury | May 17, 2010
Company News

CPEX, Arcadia Capital Advisors LLC deal

...recommended that shareholders reject a $16 per share unsolicited tender offer from private equity firm Arcadia Capital...
...Markets Corp. is advising CPEX (see BioCentury, May 3). CPEX Pharmaceuticals Inc. (NASDAQ:CPEX), Exeter, N.H. Arcadia Capital Advisors LLC...
BioCentury | May 3, 2010
Company News

CPEX, Arcadia Capital Advisors LLC deal

...Markets Corp. is advising CPEX (see BioCentury, Jan. 18). CPEX Pharmaceuticals Inc. (NASDAQ:CPEX), Exeter, N.H. Arcadia Capital Advisors LLC...
BioCentury | Jan 18, 2010
Company News

CPEX deal

...In an SEC filing, private equity firm Arcadia Capital proposed to acquire the 88% of CPEX it...
Items per page:
1 - 4 of 4